This Solicitation opportunity from Department Of Defense was posted on July 14, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
BENZONATATE CAPSULES
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
BENZONATATE CAPSULES, USP, 100 MG in bottles of 100 capsules each, are being procured under solicitation SPE2DP-26-T-4128 with a total quantity of 9 bottles, 4 bottles under CLIN 0001 and 5 bottles under CLIN 0002, to be delivered within 20 days of order placement to Building 1509, West 6th Street, Fort Stewart, GA 31314-5185 under FOB Destination terms. The item is regulated by the FDA and has a non-extendable shelf life of 36 months classified as Type I (Code Q). Packaging and marking must fully comply with MIL-STD-2073-1E and the Medical Marking Standard No. 1, superseding MIL-STD-129 for all medical items except those containing radioactive material. The product must be stored at controlled room temperature between 20°C and 25°C (68°F to 77°F) and protected from light, moisture, and humidity. The solicitation references the DLA Master List of Technical and Quality Requirements via RA001 and mandates removal of government identification from non-accepted supplies under RQ011. Multiple FAR and DFARS clauses are incorporated, including those related to sustainable products, hazardous material identification, safeguarding covered defense information per NIST SP 800-171, cyber incident reporting, trafficking in persons, employment eligibility verification, and prohibition on toxic substances such as hexavalent chromium. The contract requires electronic submission through DIBBS by July 20, 2026, with payments processed exclusively via Wide Area WorkFlow. The contract type is unspecified but appears to follow a fixed-price structure with no price variance allowed, and award is likely based on Low-Price Technically Acceptable methodology. The solicitation incorporates clauses requiring UEI and CAGE codes for offerors, affirmative representations regarding small business status and socioeconomic certifications, and compliance with export controls and prohibitions on procurement from communist Chinese military companies. Contractors must ensure compliance with all applicable FDA regulations, hazard communication standards, and the requirement to submit Safety Data Sheets via the DLA-BSM portal. Payment and contracting administration details, including COR and payment office information, will be provided in the resulting award document.
General Info
Agency
NAICS
Place of Performance
BLDG 1509 WEST 6TH STREET, FORT STEWART, GA, 31314-5185, USASet-Aside
Timeline
Submission Closed
Organization & Contact Information
Full Description
BENZONATATE CAPSULES,USP, 100 MG, 100'S. 100 MILLIGRAMS OF BENZONATATE
ACTIVE INGREDIENT.UNIT OF ISSUE: BOTTLE (BT) OF 100ea. The capsules should be protected from light, moisture and humidity, and stored at controlled room temperature 20° to 25°C (68° to 77°F).
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description. RS020: Shelf-life requirement RS001 for a TYPE I (CODE Q) item with a shelf life of 36 months (non-extendable) applies to this item.
Shall be marked IAW the latest edition of Medical Marking Standard No. 1 https://www.dla.mil/Logistics-Operations/Packaging/
AVKARE LLC 4QGW8 P/N NDC42291-0091-01 GOLDEN STATE MEDICAL SUPPLY, INC. 1HT23 P/N NDC60429-0927-01 PROFICIENT RX LP 7GU24 P/N NDC71205-0885-00
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7017483022 0001 BT 4.000
NSN/MATERIAL:6505006601798
SPE2DP-26-T-4128
SECTION B
PR: 7017483022 PRLI: 0001 CONT’D
DELIVERY (IN DAYS):0020
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA MIL-STD-2073-1E
SPECIAL NSN/Part Number: 6505-00-660-1798 Quantity: 4 BT Purchase Request: 7017499837QTY: 5 Delivery: 20 days ADO
More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Same awarding agency
Find Active Opportunities Like This
Get AI-powered intelligence on the opportunities still open
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 650+ contractors already using CLEATUS